Intelligent Medicine Acquisition Other Current Liabilities

Intelligent Medicine Acquisition posts a other current liabilities of $610K as of December 2022. That compares with $240K in the prior-year period — up 155.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Intelligent Medicine Acquisition's other current liabilities was $240K. The latest reading is $610K — a 155.7% year-over-year increase (period ending December 2022). Use the history and growth charts on this page for a longer lookback.

Other Current Liabilities is one piece of Intelligent Medicine Acquisition's financial statement story. At $610K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for IQMD's other current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Intelligent Medicine Acquisition's other metric pages and overview cover the third.